QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma | MicrobiomeTrials← Back to trialsNCT01029873
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
TERMINATEDPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2010-02Est. Completion: 2011-11
Enrollment target: 22 participants Locations- The Angeles Clinic and Research Institute, Los Angeles, California, United States
- MD Anderson Cancer Center Orlando, Orlando, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- Carolinas Medical Center-Brumenthal Cancer Center, Charlotte, North Carolina, United States
- St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania, United States
- University of Washington, Seattle Cancer Care Center, Seattle, Washington, United States
Other microbiome trials you might be interested in
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Locally Recurrent Head and Neck Squamous Cell Carcinoma
Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma
Locally Recurrent Laryngeal Squamous Cell Carcinoma
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Hypopharyngeal Squamous Cell Carcinoma
Metastatic Laryngeal Squamous Cell Carcinoma
Metastatic Melanoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Recurrent Melanoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Lip and Oral Cavity Cancer AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Unresectable Melanoma
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in tr…
Phoenix, United StatesEst. completion Jan 1, 2027